Khalyfa Ahamed A, Ahsan Nayab, Inam Mahnoor, Ayub Kamran
Franciscan Saint James Health Olympia Fields Campus, Gastroenterology.
Southwest Gastroenterology, Gastroenterology.
Endosc Int Open. 2022 Jul 15;10(7):E978-E981. doi: 10.1055/a-1839-5401. eCollection 2022 Jul.
Papillary and duodenal carcinoma are aggressive cancers with poor 5-year survival rates. Papillectomy is a well-established treatment for early-stage carcinoma of the major papilla. Tumors arising in the minor papilla are relatively rare and there is little research available on the endoscopic management of these tumors. The purpose of this study was to establish the safety and efficacy of endoscopic papillectomy in the management of minor papillary tumors. A total of six patients undergoing ERCP for papillectomy for minor papillary tumor at four hospitals were included in this study over a period of 5 years. Papillectomy was technically successful in all six patients. Pathology revealed adenoma in three patients, adenoma with high-grade dysplasia in one patient, carcinoma in one patient, and carcinoid tumor in one patient. For follow-up, one patient had an additional tumor identified at 2 years which was found to be a recurrence of the original adenoma. This patient was treated with repeat papillectomy with no further evidence of recurrence. In our pilot study, we demonstrate that endoscopic papillectomy appears safe and effective in the management of minor papillary tumors.
乳头癌和十二指肠癌是侵袭性癌症,5年生存率较低。乳头切除术是治疗早期主乳头癌的一种成熟方法。起源于副乳头的肿瘤相对少见,关于这些肿瘤的内镜治疗的研究很少。本研究的目的是确定内镜乳头切除术治疗副乳头肿瘤的安全性和有效性。在5年的时间里,共有6例在4家医院因副乳头肿瘤接受内镜逆行胰胆管造影(ERCP)下乳头切除术的患者纳入本研究。6例患者的乳头切除术技术上均成功。病理显示3例为腺瘤,1例为高级别异型增生腺瘤,1例为癌,1例为类癌。随访中,1例患者在2年时发现有额外肿瘤,经证实为原腺瘤复发。该患者接受了再次乳头切除术治疗,无进一步复发迹象。在我们的初步研究中,我们证明内镜乳头切除术治疗副乳头肿瘤似乎是安全有效的。